BIRC3 and breast cancer: On the other hand, Ho et al. demonstrated that doxorubicin treatment in MDA-MB-231 breast cancer cells did not increase p65 phosphorylation at serine 536 at any time from 10 minutes up to 24 hours and concordantly demonstrated a decrease in cIAP2 transcription [12].